Sumary of EU agency to confirm AstraZeneca COVID-19 vaccine blood clot link, official says:
- ROME – A top official at the European Medicines Agency says there is a causal link between AstraZeneca’s coronavirus vaccine and rare blood clots, but that it’s unclear what the connection is and the benefits of taking the vaccine still outweigh the risks of getting COVID-19..
- Marco Cavaleri, head of health threats and vaccine strategy at the Amsterdam-based agency, told Rome’s Il Messaggero newspaper on Tuesday that the EU medicines regulator is preparing to make a more definitive statement on the topic this week..
- Asked about Cavaleri comments, the EMA press office said its evaluation “has not yet reached a conclusion and the review is currently ongoing.”.
- But he stressed the risk-benefit analysis remained positive for the AstraZeneca jab, even for young women who appear to be more affected by the clots….